GNC on Wednesday postponed for a second time a vote on a proposed joint venture with Harbin Pharmaceutical Group Holdings Co., Ltd of China.

The Pittsburgh-based health and wellness retailer made the announcement early Wednesday, hours before shareholders were to submit votes on the proposal that would give Harbin five of 11 seats on the GNC board.

Harbin also has agreed to invest $300 million in GNC, making it the company’s largest shareholder.

A meeting for an initial vote was held on April 25 but was quickly adjourned after only 36 percent of shareholder proxies had been submitted.

Advertise with us

On Wednesday, GNC said about 45 percent of the shareholders have submitted proxies to vote, still short of the required majority. In a release, the company said 93 percent of the proxies submitted as of Tuesday favored the strategic partnership with Harbin.

The meeting is now scheduled for May 17 at the Omni William Penn Hotel, Downtown.

GNC shares closed Wednesday at $3.15, down 22 cents, after hitting a 52-week low of $3.08 earlier in the day.

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.

Updated at 4:30 p.m. May 9, 2018.